We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intergenerational Transmission of Terror

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00320437
Recruitment Status : Unknown
Verified November 2006 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
First Posted : May 3, 2006
Last Update Posted : November 30, 2006
Sponsor:
Information provided by:
Hadassah Medical Organization

Brief Summary:
Our aim is examine avenues by which mothers can transmit their trauma to their children.

Condition or disease Phase
Anxiety Trauma Stress Disorders Phase 1

Detailed Description:
The goal of the study is to test for genetic bases and Gene x Environment interactions on the development of difficulties, particularly stress disorders, in young children whose mother were exposed to terror before they were born.

Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: The Intergenerational Transmission of Trauma From Terror: A Developmental Perspective
Study Start Date : May 2007
Estimated Study Completion Date : December 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Pregnant women who were exposed to terror in the last 5 years
  • Matched Controls

Exclusion Criteria:

  • Does not speak Hebrew or English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00320437


Contacts
Contact: David Mankuta, MD MHA 00 972 507 874788 mankuta@yahoo.com
Contact: Hadas Lemberg, PhD 00 972 2 677572 Ihadas@hadassah.org.il

Locations
Israel
Hadassah University Hospital Not yet recruiting
Jerusalem, Ein Kerem, Israel, 91120
Contact: David Mankuta, MD MHA    00 972 507 874788    mankuta@yahoo.com   
Contact: Hadas Lemberg, PhD    00 972 2 6776095    Ihadas@hadassah.org.il   
Principal Investigator: David Mankuta, MD MHA         
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Steven Faraone, PhD State University of New York - Upstate Medical University

ClinicalTrials.gov Identifier: NCT00320437     History of Changes
Other Study ID Numbers: terror HMO-CTIL
First Posted: May 3, 2006    Key Record Dates
Last Update Posted: November 30, 2006
Last Verified: November 2006

Keywords provided by Hadassah Medical Organization:
trauma
anxiety
antenatal
mothers
children
Gene x Environment Interaction

Additional relevant MeSH terms:
Wounds and Injuries